Expression of HER3 was found to differ between pancreatobiliary and intestinal type adenocarcinomas and to be a favourable prognostic factor, however not independent, in intestinal type adenocarcinoma. Here, ERBB3 is linked to gastric intestinal type adenocarcinoma.